Abstract
Background and study aims The aim of the present study was to determine whether blue-laser imaging (BLI) reduced
the miss rate of colon adenomatous lesions compared with conventional white-light
imaging (WLI).
Patients and methods This was a prospective randomized study of patients undergoing screening and/or surveillance
colonoscopy at Saga Medical School, Japan. A total of 127 patients were randomized
to tandem colonoscopy with BLI followed by WLI (BLI-WLI group) or WLI followed by
WLI (WLI-WLI group). The main outcome measure was the adenoma miss rate.
Results The proportion of patients with adenomatous lesions was 62.5 % (40 /64) in the BLI-WLI
group and 63.5 % (40 /63) in the WLI-WLI group. The total number of adenomatous lesions
detected in the first inspection of the BLI-WLI and WLI-WLI groups was 179 and 108,
respectively, compared with 182 and 120 in the second inspection, respectively. The
miss rate in the BLI-WLI group was (1.6 %), which was significantly less than that
in the WLI-WLI group (10.0 %, P = 0.001).
Conclusions Colonoscopy using BLI resulted in a lower colon adenoma miss rate than WLI.
Trial registration UMIN 000015677.